A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

计划入组 66 人 · 首次发布于 2026 年 4 月 22 日

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

计划入组 26 人 · 首次发布于 2024 年 1 月 30 日

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

计划入组 1,320 人 · 首次发布于 2021 年 6 月 4 日

CAN-10

BBI-10

Interleukin-10

iFreeETF US Treasury Bond 7-10 Year Hdg

United States

景时（杭州）药业有限公司

ANTIBIOTICE SA

Romania

Dispatch Bio Doses First Patient in Phase 1 Trial of DISP-10, a Novel Synthetic-Antigen CAR T Immunotherapy for Advanced GI Cancers, Secures FDA Fast Track Designation

FDA Approves Remdesivir as First Official COVID-19 Treatment

FDA Approves Genentech's Itovebi for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation